Key Highlights

  • Axanzo is the name AkzoNobel and Axalta (NYSE:AXTA) announced on October 15, 2026, for the combined coatings company. Closing is expected in early 2027, subject to regulatory approvals, and both companies operate independently until then.
  • USD 25 billion is the enterprise value of the all-stock merger of equals announced in November 2025, with AkzoNobel holders to own 55 percent and Axalta holders 45 percent. Axalta shareholders receive 0.6539 AkzoNobel shares per Axalta share.
  • USD 33.72 was the Axalta (NYSE:AXTA) close on October 15, up 1.63 percent, per published market data. That is about 12.7 percent below the 52-week high of USD 38.61, simple arithmetic, and the name reveal added no new financial terms.
  • USD 600 million of run-rate synergies is the identified target, with 90 percent expected within three years of closing. Combined 2024 revenue was about USD 17 billion, with adjusted EBITDA of USD 3.3 billion, according to the November 2025 announcement.

What the Name Change Signals

The announcement on October 15, 2026, gave the merged company its name, Axanzo, and an envisaged ticker of AXZ on the NYSE and Euronext Amsterdam. The group would hold about 100 brands in more than 160 countries. AkzoNobel chief executive Greg Poux-Guillaume would lead it, with Axalta chief executive Chris Villavarayan as deputy chief executive. Both shareholder groups approved the merger on August 5, 2026, and the SEC declared the AkzoNobel registration statement effective on June 23, 2026.

How the Merger Works

Axalta (NYSE:AXTA) holders will receive AkzoNobel shares at a fixed ratio of 0.6539, so the value they receive moves with the AkzoNobel share price until closing, not with a fixed cash amount. AkzoNobel will also pay its own holders a special cash dividend of 2.5 billion euro on top of the exchange ratio, payable to AkzoNobel holders only. The company will have dual headquarters in Amsterdam and Philadelphia, with AkzoNobel keeping its Dutch domicile. Axalta pays no dividend, per published market data.

Risks and What to Watch

Remaining risks centre on regulatory approvals, including antitrust reviews, and on integration, since USD 600 million of synergies depends on execution. The fixed ratio also exposes Axalta holders to AkzoNobel share price swings. Published market data show a consensus Hold rating with an average target of USD 38.18. Axalta third quarter results are estimated for October 29, 2026, an unconfirmed date. AkzoNobel trades in Amsterdam as AKZA and is left untagged here because no US exchange listing was verified.

Where Things Stand

The name matters less than the closing conditions. Axanzo is a branding step, and it changes no terms: Axalta (NYSE:AXTA) holders still swap into AkzoNobel shares at 0.6539, with a 45 percent stake in the combined group. Both shareholder votes are done, which leaves regulatory clearance and execution as the main uncertainties before an early 2027 closing. The shares rose 1.63 percent on the day, a modest move that suggests the market treated the announcement as housekeeping. The next catalysts are third quarter results and any regulatory decisions.